Avita.png
AVITA Medical Reports Second Quarter Financial Results
08. August 2024 16:04 ET | AVITA Medical
AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.
Avita.png
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04. Januar 2024 09:00 ET | AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
Avita.png
AVITA Medical to Host Investor Webinar Briefing
04. Dezember 2023 09:00 ET | AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
Avita.png
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09. November 2023 09:00 ET | AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
RCAR Press Release Oct 29 2020
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
22. Oktober 2020 16:35 ET | RenovaCare, Inc.
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Robert W Cook
Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Board Secretary
16. Juni 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare, Inc.
RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services
10. Juni 2020 08:36 ET | RenovaCare, Inc.
ROSELAND, N.J., June 10, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...